Trials / Conditions / Group B Streptococcal Infection

Group B Streptococcal Infection

11 registered clinical trials studyying Group B Streptococcal Infection — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry NCT06896526	Precia Group	—
Not Yet Recruiting	Group B Streptococcus Infection and PROM Incidince NCT06735703	Assiut University	—
Unknown	Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PRE NCT05832502	St George's, University of London	Phase 2
Completed	Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women NCT05154578	Minervax ApS	Phase 2
Completed	Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Ha NCT04596878	Minervax ApS	Phase 2
Withdrawn	Time Frame for GBS Screening NCT04116645	Rambam Health Care Campus	—
Withdrawn	MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI : A Follow up STUDY NCT04227730	Fayoum University Hospital	—
Terminated	Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization NCT02814318	TriHealth Inc.	—
Completed	Effect of Probiotics on GBS Colonization Status During Pregnancy: A Pilot Randomized Controlled Trial NCT02528981	Toronto Metropolitan University	N/A
Completed	Simplified GBS Screening and Prevalence of ESBL in Pregnant Women NCT02142933	University Hospital, Basel, Switzerland	N/A
Completed	Oral Probiotics Reduce Group B Streptococci Colonization in Pregnant Women NCT01577108	China Medical University Hospital	N/A